LSX Biotech Startup CEO Forum

Biotech Start-up / Early Stage CEO Forum

Tuesday, June 21 4:00pm - 5:30pm
Room 204

Agenda | Hosts | Book

Open to CEO, Founder, Co-Founder, President, Chairman or c-suite executive (CFO, CBO, CCO, CSO, CMO) of US-based, pre-series A-funded, therapeutic Biotech companies.

Free to attend, pre-registration only, Chatham House Rule forum where all participants are active discussants. 

  • Benchmark yourself against your peers
  • Uncover key factors of success
  • Share war stories and common challenges
  • Engage in peer-to-peer discussion
  • Make meaningful connections
  • Find new ways to help your business thrive


There’s nothing that comes close to hearing the honest advice and experience of peers treading the same path as you. LSX’s CEO Forums offer executives the chance to exchange ideas with and seek advice from peers in a private group setting. They are an opportunity to share learnings, best practice and some great thinking, as well as meeting other influential people to support your business journey. Capped at 20 participants, the forums operate under strict Chatham House Rule.

4:00pm Opening remarks and introductions

4:05pm Efficient and Effective IP Due Diligence

Attracting investment, licensing opportunities, and partnerships is often of paramount importance to many companies. In industries where intellectual property (IP) constitutes the bulk of a company’s value, the strength of its patent portfolio can make or break its prospects for continued success. When millions of dollars or even entire businesses are at stake, IP due diligence is essential to determining the full value of the IP involved, assessing and evaluating the risks, and determining whether the transaction is in each party’s best interests.

  • High-level questions to be answered before diligence commences
  • The ideal composition of experts for the diligence team
  • How to protect yourself during the diligence

Gwilym Attwell, Principal, Fish & Richardson

Gwilym Attwell, Principal, Fish & Richardson

4:20pm Q&A

4:30pm Designing a Development Strategy to Maximize Early Exit

Robb Lawrence, SVP, Commercial Strategy Solutions, Premier Consulting

Robb Lawrence, SVP, Commercial Strategy Solutions, Premier Consulting

4:45pm Q&A

4:55pm How to make a splash in Biotech – strategic partnering and fundraising routes

Judy Chou, CEO and President, AltruBio, Inc.

Judy Chou, CEO and President, AltruBio, Inc.

5:05pm General Discussion (suggested topics to include but not limited to)

  • Fundraising challenges and opportunities
  • Overcoming barriers to market and regulatory approval
  • Creating the right deals and partnerships to move your business forward
  • Internationalising and company growth

5:30pm Wrap-up


    Fish & Richardson 300x    Premier Consulting Logo